Clinical Trial Update: Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating methylphenidate hydrochloride extended-release tablets as augmentation therapy in obsessive-compulsive disorder; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Methylphenidate hydrochloride extended-release tablets (methylphenidate hydrochloride)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Obsessive Compulsive Disorder | Phase 4 | Status: COMPLETED